Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0249 | 0.3292 | 1 | |
Brugia malayi | Bromodomain containing protein | 0.004 | 0.0318 | 0.0731 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0054 | 0.0508 | 0.0322 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0038 | 0.0592 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0063 | 0.0639 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0054 | 0.0508 | 0.7949 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0054 | 0.0508 | 0.7949 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.0283 | 0.4437 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0283 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0192 | 0.2769 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.0283 | 0.4094 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.0491 | 0.169 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0219 | 0.2861 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0054 | 0.0774 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0038 | 0.0592 |
Plasmodium falciparum | peptide deformylase | 0.072 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0283 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0031 | 0.0192 | 0.027 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0491 | 0.169 |
Trichomonas vaginalis | set domain proteins, putative | 0.0249 | 0.3292 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0447 | 0.1535 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0283 | 0.0604 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.072 | 1 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0038 | 0.0283 | 0.4427 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0275 | 0.3658 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0054 | 0.0508 | 0.1748 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0255 | 0.05 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0054 | 0.0508 | 0.7949 |
Brugia malayi | Bromodomain containing protein | 0.0079 | 0.0868 | 0.2734 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0275 | 0.3658 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0283 | 0.5 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0275 | 0.3658 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0255 | 0.0862 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0054 | 0.0508 | 0.7949 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0054 | 0.0508 | 0.7334 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.0283 | 0.4437 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0275 | 0.3658 | 1 |
Plasmodium vivax | peptide deformylase, putative | 0.072 | 1 | 1 |
Treponema pallidum | polypeptide deformylase (def) | 0.072 | 1 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0066 | 0.0692 | 1 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0275 | 0.3658 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0283 | 0.4094 |
Brugia malayi | MAP kinase sur-1 | 0.0054 | 0.0508 | 0.1422 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0275 | 0.3658 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.0082 | 0.1287 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0049 | 0.0447 | 0.7 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0804 | 0.2786 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0049 | 0.0447 | 0.6458 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.0491 | 0.1361 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0049 | 0.0447 | 0.7 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0355 | 0.1211 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0275 | 0.3658 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0319 | 0.1087 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.0082 | 0.1188 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0283 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0063 | 0.0639 | 1 |
Toxoplasma gondii | hypothetical protein | 0.072 | 1 | 1 |
Mycobacterium ulcerans | peptide deformylase | 0.072 | 1 | 0.5 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0175 | 0.2743 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.072 | 1 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0049 | 0.0447 | 0.6458 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0383 | 0.1312 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0031 | 0.0192 | 0.3001 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0038 | 0.0546 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0038 | 0.0283 | 0.4427 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0054 | 0.0156 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.072 | 1 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.0082 | 0.1287 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0031 | 0.0192 | 0.2769 |
Brugia malayi | Pre-SET motif family protein | 0.0219 | 0.2861 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.0491 | 0.1361 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0255 | 0.3683 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0054 | 0.0508 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.